Platinib manufacturing company? Where can I buy it?

Pralsetinib is an anti-tumor drug developed and produced by Pfizer. It was approved for marketing by the U.S. FDA on 9 2020 on 94 In n>2022March, platinib will be launched in China and has been included in medical insurance. Domestic imported drugs are priced at pharmacies100mg*120tablets18880 yuan. Patients who need this medicine can buy it at local hospitals or pharmacies.

Patients receivingplatinib may develop severe, life-threatening, and fatal interstitial lung disease (ILD) pneumonia, of patients receivingplatinib 10% developed pneumonia, of which 2.7% were grade 3-4 and 0.5% were fatal reactions. Monitoring is indicated for pulmonary symptoms of ILD/pneumonia. If a patient develops acute or worsening respiratory symptoms, it may be an indication of ILD (e.g., dyspnea, cough, and fever) span>, discontinue platinib and immediately investigateILD. Depending on the severity of the confirmed ILD, suspend, reduce the dose, or permanently discontinue platinib.

29%of the patients had hypertension, of which 14% had grade 3 hypertension. Overall, 7%of patients discontinued dosing due to hypertension, and 3.2%reduced dosing due to hypertension. Treatment-emergent hypertension is usually controlled with antihypertensive medications. Do not use platinib in patients with uncontrolled hypertension. Optimize blood pressure before initiating platinib. Monitor blood pressure after 1 week and at least monthly thereafter and as clinically indicated. Initiate or adjust antihypertensive treatment appropriately. Depending on severity, withhold, reduce dose, or permanently discontinue platinib.Serious hepatic adverse reactions occurred in 2.1%of patients who received platinib. 69% of patientsAST were elevated, including 5% 3 grade or 4 grade patients, 46% ALT elevation, including 6% grade 3 or Grade 4 patients[See adverse reactions(6.1)].The median time to the first AST elevation is 15days(Range:5days to1.5years), the median time to ALT elevation was 22 days(Range:7days to1.7years). Before starting to take Platinib, monitor AST and ALT every 2 weeks for the first months, and then monthly as clinically indicated. Depending on severity, withhold, reduce dose, or permanently discontinue platinib. Serious bleeding events, including fatal bleeding, may occur with platinib. 2.5%of patients receiving platinib treatment experienced ≥ 3 grade bleeding events, including 1 fatal bleeding event. Platinib should be permanently discontinued in patients with severe or life-threatening bleeding. Adverse reactions have been reported in cases of tumor lysis syndrome (TLS) in patients with medullary thyroid cancer treated with platinib. Patients may be at risk for TLS if they have rapidly growing tumors, high tumor burden, renal dysfunction, or dehydration. Monitor at-risk patients closely, consider appropriate precautions, including hydration, and treat as clinically indicated. Impaired wound healing occurs in patients receiving drugs that inhibit the vascular endothelial growth factor (VEGF) signaling pathway. Therefore, Platinib has the potential to adversely affect wound healing.

Discontinue platinib at least before elective surgery. After major surgery at leastDo not administer Platinib for 2 weeks until the wound is completely healed. Resume use after wound healing complications are resolved. The safety of platinib has not been determined. This medicine also has an overseas version. The retail price of Lucius Pharmaceuticals in Laos is more than 1,000 yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0

xa0